Literature DB >> 26297765

Human Mucosa-Associated Invariant T Cells Accumulate in Colon Adenocarcinomas but Produce Reduced Amounts of IFN-γ.

Patrik Sundström1, Filip Ahlmanner1, Paulina Akéus1, Malin Sundquist1, Samuel Alsén1, Ulf Yrlid1, Lars Börjesson2, Åsa Sjöling3, Bengt Gustavsson2, S B Justin Wong4, Marianne Quiding-Järbrink5.   

Abstract

Mucosa-associated invariant T (MAIT) cells are innate-like T cells with a conserved TCR α-chain recognizing bacterial metabolites presented on the invariant MHC-related 1 molecule. MAIT cells are present in intestinal tissues and liver, and they rapidly secrete IFN-γ and IL-17 in response to bacterial insult. In colon cancer, IL-17-driven inflammation promotes tumor progression, whereas IFN-γ production is essential for antitumor immunity. Thus, tumor-associated MAIT cells may affect antitumor immune responses by their secreted cytokines. However, the knowledge of MAIT cell presence and function in tumors is virtually absent. In this study, we determined the frequency, phenotype, and functional capacity of MAIT cells in colon adenocarcinomas and unaffected colon lamina propria. Flow cytometric analyses showed significant accumulation of MAIT cells in tumor tissue, irrespective of tumor stage or localization. Colonic MAIT cells displayed an activated memory phenotype and expression of chemokine receptors CCR6 and CCR9. Most MAIT cells in unaffected colon tissues produced IFN-γ, whereas only few produced IL-17. Colonic MAIT cells also produced TNF-α, IL-2, and granzyme B. In the tumors, significantly lower frequencies of IFN-γ-producing MAIT cells were seen, whereas there were no differences in the other cytokines analyzed, and in vitro studies showed that secreted factors from tumor tissue reduced IFN-γ production from MAIT cells. In conclusion, MAIT cells infiltrate colon tumors but their ability to produce IFN-γ is substantially reduced. We suggest that MAIT cells have the capacity to promote local immune responses to tumors, but factors in the tumor microenvironment act to reduce MAIT cell IFN-γ production.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26297765     DOI: 10.4049/jimmunol.1500258

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

Review 1.  Microbiota as a mediator of cancer progression and therapy.

Authors:  Jillian L Pope; Sarah Tomkovich; Ye Yang; Christian Jobin
Journal:  Transl Res       Date:  2016-08-03       Impact factor: 7.012

Review 2.  Mucosal-associated invariant T cells and disease.

Authors:  Amine Toubal; Isabelle Nel; Sophie Lotersztajn; Agnès Lehuen
Journal:  Nat Rev Immunol       Date:  2019-10       Impact factor: 53.106

Review 3.  Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.

Authors:  Benjamin Ruf; Bernd Heinrich; Tim F Greten
Journal:  Cell Mol Immunol       Date:  2020-11-24       Impact factor: 11.530

4.  MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutations.

Authors:  Francois Vergez; Emmanuel Treiner; Thibault Comont; Marie-Laure Nicolau-Travers; Sarah Bertoli; Christian Recher
Journal:  Cancer Immunol Immunother       Date:  2021-09-03       Impact factor: 6.968

Review 5.  An Unconventional View of T Cell Reconstitution After Allogeneic Hematopoietic Cell Transplantation.

Authors:  Hana Andrlová; Marcel R M van den Brink; Kate A Markey
Journal:  Front Oncol       Date:  2021-02-18       Impact factor: 6.244

6.  Exercise training partially rescues impaired mucosal associated invariant t-cell mobilization in breast cancer survivors compared to healthy older women.

Authors:  Erik D Hanson; Lauren C Bates; Elizabeth P Harrell; David B Bartlett; Jordan T Lee; Chad W Wagoner; Mohamdod S Alzer; Dean J Amatuli; Brian C Jensen; Allison M Deal; Hyman B Muss; Kirsten A Nyrop; Claudio L Battaglini
Journal:  Exp Gerontol       Date:  2021-06-16       Impact factor: 4.253

Review 7.  Mouse models illuminate MAIT cell biology.

Authors:  Huimeng Wang; Zhenjun Chen; James McCluskey; Alexandra J Corbett
Journal:  Mol Immunol       Date:  2020-12-22       Impact factor: 4.407

8.  Cryopreservation of Whole Tumor Biopsies from Rectal Cancer Patients Enable Phenotypic and In Vitro Functional Evaluation of Tumor-Infiltrating T Cells.

Authors:  Frank Liang; Azar Rezapour; Peter Falk; Eva Angenete; Ulf Yrlid
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

9.  Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response.

Authors:  Benjamin Ruf; Vanessa V Catania; Simon Wabitsch; Chi Ma; Laurence P Diggs; Qianfei Zhang; Bernd Heinrich; Varun Subramanyam; Linda L Cui; Marie Pouzolles; Christine N Evans; Raj Chari; Shunsuke Sakai; Sangmi Oh; Clifton E Barry; Daniel L Barber; Tim F Greten
Journal:  Cancer Immunol Res       Date:  2021-06-30       Impact factor: 12.020

10.  Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1.

Authors:  Hannah C Jeffery; Bonnie van Wilgenburg; Ayako Kurioka; Krishan Parekh; Kathryn Stirling; Sheree Roberts; Emma E Dutton; Stuart Hunter; Daniel Geh; Manjit K Braitch; Jeremy Rajanayagam; Tariq Iqbal; Thomas Pinkney; Rachel Brown; David R Withers; David H Adams; Paul Klenerman; Ye H Oo
Journal:  J Hepatol       Date:  2015-12-29       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.